Vivoryon Therapeutics N.V. sell ReynadJ
Start price
10.12.24
/
0%
€2.12
Target price
10.12.25
-
Performance (%)
-26.15%
End price
11.12.25
€1.56
Summary
This prediction ended on 11.12.25 with a price of €1.56. The prediction for Vivoryon Therapeutics N.V. closed with a convincing performance of -26.15%. This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vivoryon Therapeutics N.V. | -5.963% | -5.963% | -22.912% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to ReynadJ what are the pros and cons of Vivoryon Therapeutics N.V. for the foreseeable future?
Pros
Cons
Risky Investment
Below average Marketposition
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
High valuation
Low dividend yield expected
Revenue decline/stagnation expected
negative Cash Flow expected
Comments by ReynadJ for this prediction
In the thread Vivoryon Therapeutics AG diskutieren
Sell Vivoryon Therapeutics N.V.
In the thread Trading Vivoryon Therapeutics AG
Die von ReynadJ gewählte maximale Laufzeit wurde überschritten